Tag: antisense oligonucleotide
Phase 3 Trial of Bepirovirsen Shows Promise for Chronic Hepatitis B Treatment
Phase 3 clinical trial results for bepirovirsen, a novel antisense oligonucleotide therapy for chronic hepatitis B, published in The New…
Submit Your Paper to GMJ
No APC until January 2027.